Literature DB >> 10873976

The lens in hereditary hyperferritinaemia cataract syndrome contains crystalline deposits of L-ferritin.

A D Mumford1, I A Cree, J D Arnold, M C Hagan, K C Rixon, J J Harding.   

Abstract

BACKGROUND/AIM: Hereditary hyperferritinaemia cataract syndrome (HHCS) is an autosomal dominant disorder characterised by elevated serum L-ferritin and bilateral cataracts. The ocular manifestations of this disorder are poorly studied. This study therefore sought to determine the origin of cataracts in HHCS.
METHODS: L-ferritin ELISA, immunohistochemical and ultrastructural analysis of a lens nucleus from an HHCS individual.
RESULTS: The HHCS lens L-ferritin content was 147 microg/g dry weight of lens compared with <16 microg/g for a non-HHCS control cataract lens. The cataract comprised discrete crystalline inclusions with positive staining with anti-L-ferritin but not anti-H-ferritin.
CONCLUSIONS: This unusual finding of crystalline opacities in the lens may be unique to HHCS and is likely to result from disturbed metabolism of L-ferritin within the lens or an abnormal interaction between L-ferritin and lens proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10873976      PMCID: PMC1723562          DOI: 10.1136/bjo.84.7.697

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  16 in total

1.  Hereditary hyperferritinemia-cataract syndrome: relationship between phenotypes and specific mutations in the iron-responsive element of ferritin light-chain mRNA.

Authors:  M Cazzola; G Bergamaschi; L Tonon; E Arbustini; M Grasso; E Vercesi; G Barosi; P E Bianchi; G Cairo; P Arosio
Journal:  Blood       Date:  1997-07-15       Impact factor: 22.113

2.  Alpha-crystallin can function as a molecular chaperone.

Authors:  J Horwitz
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

Review 3.  Conformational disease.

Authors:  R W Carrell; D A Lomas
Journal:  Lancet       Date:  1997-07-12       Impact factor: 79.321

Review 4.  Function and regulation of transferrin and ferritin.

Authors:  P Ponka; C Beaumont; D R Richardson
Journal:  Semin Hematol       Date:  1998-01       Impact factor: 3.851

5.  Hyperferritinaemia in the absence of iron overload.

Authors:  J D Arnold; A D Mumford; J O Lindsay; U Hegde; M Hagan; J R Hawkins
Journal:  Gut       Date:  1997-09       Impact factor: 23.059

Review 6.  Ferritin in human tissues and serum.

Authors:  M Worwood
Journal:  Clin Haematol       Date:  1982-06

7.  Hereditary hyperferritinemia-cataract syndrome: two novel mutations in the L-ferritin iron-responsive element.

Authors:  A D Mumford; T Vulliamy; J Lindsay; A Watson
Journal:  Blood       Date:  1998-01-01       Impact factor: 22.113

8.  The effect of ascorbic acid and ferric ammonium citrate on iron uptake and storage in lens epithelial cells.

Authors:  M Goralska; J Harned; L N Fleisher; M C McGahan
Journal:  Exp Eye Res       Date:  1998-06       Impact factor: 3.467

9.  Mutation in the iron responsive element of the L ferritin mRNA in a family with dominant hyperferritinaemia and cataract.

Authors:  C Beaumont; P Leneuve; I Devaux; J Y Scoazec; M Berthier; M N Loiseau; B Grandchamp; D Bonneau
Journal:  Nat Genet       Date:  1995-12       Impact factor: 38.330

10.  Molecular basis for the recently described hereditary hyperferritinemia-cataract syndrome: a mutation in the iron-responsive element of ferritin L-subunit gene (the "Verona mutation")

Authors:  D Girelli; R Corrocher; L Bisceglia; O Olivieri; L De Franceschi; L Zelante; P Gasparini
Journal:  Blood       Date:  1995-12-01       Impact factor: 22.113

View more
  12 in total

Review 1.  Recent advance in molecular iron metabolism: translational disorders of ferritin.

Authors:  Junji Kato; Yoshiro Niitsu
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

Review 2.  Iron homeostasis and eye disease.

Authors:  Allison Loh; Majda Hadziahmetovic; Joshua L Dunaief
Journal:  Biochim Biophys Acta       Date:  2008-11-14

3.  Crystal cataracts: human genetic cataract caused by protein crystallization.

Authors:  A Pande; J Pande; N Asherie; A Lomakin; O Ogun; J King; G B Benedek
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

4.  The hereditary hyperferritinemia-cataract syndrome: a family study.

Authors:  Javier Álvarez-Coca-González; María-Isabel Moreno-Carralero; Jorge Martínez-Pérez; Manuel Méndez; Marta García-Ros; María-Josefa Morán-Jiménez
Journal:  Eur J Pediatr       Date:  2010-07-09       Impact factor: 3.183

5.  Hepcidin levels in hereditary hyperferritinemia: Insights into the iron-sensing mechanism in hepatocytes.

Authors:  Jayantha Arnold; Arvind Sangwaiya; Vijay Manglam; Mark Thursz; Caroline Beaumont; Caroline Kannengiesser; Mark Busbridge
Journal:  World J Gastroenterol       Date:  2010-07-28       Impact factor: 5.742

Review 6.  Brain iron homeostasis: from molecular mechanisms to clinical significance and therapeutic opportunities.

Authors:  Neena Singh; Swati Haldar; Ajai K Tripathi; Katharine Horback; Joseph Wong; Deepak Sharma; Amber Beserra; Srinivas Suda; Charumathi Anbalagan; Som Dev; Chinmay K Mukhopadhyay; Ajay Singh
Journal:  Antioxid Redox Signal       Date:  2013-08-15       Impact factor: 8.401

7.  Hyperferritinemia without iron overload in patients with bilateral cataracts: a case series.

Authors:  Arne Kröger; Esther B Bachli; Andrew Mumford; Christoph Gubler
Journal:  J Med Case Rep       Date:  2011-09-21

8.  A child with hyperferritinemia: case report.

Authors:  Melania Serra; Filomena Longo; Antonella Roetto; Alessandro Sandri; Antonio Piga
Journal:  Ital J Pediatr       Date:  2011-05-12       Impact factor: 2.638

9.  Ocular signs in Wilson disease.

Authors:  Deepak S Amalnath; D K S Subrahmanyam
Journal:  Ann Indian Acad Neurol       Date:  2012-07       Impact factor: 1.383

10.  Noncoding variation of the gene for ferritin light chain in hereditary and age-related cataract.

Authors:  Thomas M Bennett; Giovanni Maraini; Chongfei Jin; Wenmin Sun; J Fielding Hejtmancik; Alan Shiels
Journal:  Mol Vis       Date:  2013-04-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.